Yuusuke Tamura
Inventor
Stats
- 7 US patents issued
- 17 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 17 US Applications Filed
- 151 Total Citation Count
- May 2, 2019 Most Recent Filing
- Apr 23, 2008 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| BRIDGESTONE CORPORATION | 1
3 | 2010
2015 |
| Shionogi & Co., Ltd. | 2
1 1 3 1 2 1 | 2008
2009 2010 2012 2013 2014 2015 |
| ONCOTHERAPY SCIENCE, INC. | 1
| 2011
|
Inventor Addresses
| Address | Duration |
|---|---|
| Kodaira, JP | Jul 12, 16 - Dec 13, 16 |
| Osaka, JP | Sep 29, 11 - Dec 24, 19 |
| Osaka-fu, JP | Mar 25, 10 - Mar 25, 10 |
| Osaka-shi, JP | Jul 05, 12 - Jul 05, 12 |
| Tokyo, JP | Jul 14, 16 - Dec 15, 16 |
| Toyonaka, JP | Feb 13, 18 - May 29, 18 |
| Toyonaka-shi, JP | Jul 23, 15 - May 24, 18 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 12 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
| B29C: | SHAPING OR JOINING OF PLASTICS; SHAPING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL; AFTER- TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 10513513 | 2019 | Salts of quinazoline derivative or crystals thereof, and the process for producing thereof | 1 |
| 10478425 | 2019 | 5-phenylazaindole derivative having AMPK-activating activity | 0 |
| 10406140 | 2019 | 5-substituted benzimidazole and 5-substituted azabenzimidazole derivative both having AMPK activation effect | 0 |
| 2019/0256,506 | 2019 | SALTS OF QUINAZOLINE DERIVATIVE OR CRYSTALS THEREOF, AND THEPROCESS FOR PRODUCING THEREOF | 0 |
| 10329285 | 2019 | Salts of quinazoline derivative or crystals thereof, and the process for producing thereof | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.